Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4830039 | 5924444 | I | 4830039-3 | 20051107 | 20051117 | EXP | GB-ABBOTT-05P-167-0316749-00 | ABBOTT | 73 | YR | F | Y | 20051117 | UNITED KINGDOM |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4830039 | 1006632581 | PS | ERYTHROMYCIN | 1 | ORAL | UNKNOWN | 061621 | ||||
| 4830039 | 1006632582 | I | SIMVASTATIN | 1 | ORAL | UNKNOWN |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 4830039 | 1006632581 | RENAL IMPAIRMENT |
| 4830039 | 1006632582 | HYPERCHOLESTEROLAEMIA |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 4830039 | DS |
| 4830039 | HO |
Reactions reported
| Event ID | PT |
|---|---|
| 4830039 | DRUG INTERACTION |
| 4830039 | RENAL FAILURE |
| 4830039 | RHABDOMYOLYSIS |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 4830039 | 1006632582 | 20040115 |